The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis

[1]  N. Arden,et al.  Osteoarthritis year 2013 in review: clinical. , 2013, Osteoarthritis and cartilage.

[2]  Yucong Zou,et al.  Correlation of fractalkine concentrations in serum and synovial fluid with the radiographic severity of knee osteoarthritis , 2013, Annals of clinical biochemistry.

[3]  D. Saris,et al.  An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid. , 2013, Osteoarthritis and cartilage.

[4]  P. Richette,et al.  Biologic agents in osteoarthritis: hopes and disappointments , 2013, Nature Reviews Rheumatology.

[5]  M. Mohamadzadeh,et al.  Macrophages and chemokines as mediators of angiogenesis , 2013, Front. Physiol..

[6]  A. Haseeb,et al.  Immunopathogenesis of osteoarthritis. , 2013, Clinical immunology.

[7]  J. Sokolove,et al.  Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations , 2013, Therapeutic advances in musculoskeletal disease.

[8]  S. Goldring,et al.  The role of synovitis in osteoarthritis pathogenesis. , 2012, Bone.

[9]  P. Proost,et al.  Overview of the mechanisms regulating chemokine activity and availability. , 2012, Immunology letters.

[10]  C. Martínez-A,et al.  Chemokine receptor oligomerization: a further step toward chemokine function. , 2012, Immunology letters.

[11]  B. Moser,et al.  Antimicrobial Activities of Chemokines: Not Just a Side-Effect? , 2012, Front. Immun..

[12]  S. Goldring,et al.  Osteoarthritis: a disease of the joint as an organ. , 2012, Arthritis and rheumatism.

[13]  A. Zlotnik,et al.  The chemokine superfamily revisited. , 2012, Immunity.

[14]  A. Koch,et al.  Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions , 2012, Front. Immun..

[15]  D. Su,et al.  [Effects of fractalkine on the expression of inflammatory substances in LPS-activated microglia cells]. , 2011, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[16]  Steffen Jung,et al.  In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. , 2011, Blood.

[17]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[18]  G. Livshits,et al.  Quantitative genetic study of amphiregulin and fractalkine circulating levels--potential markers of arthropathies. , 2011, Osteoarthritis and cartilage.

[19]  R. Ransohoff,et al.  Analyses of phenotypic and functional characteristics of CX3CR1‐expressing natural killer cells , 2011, Immunology.

[20]  A. Richmond.  Chemokine research moves on. , 2011, Experimental cell research.

[21]  A. Kawada,et al.  Eotaxin-3/CC Chemokine Ligand 26 Is a Functional Ligand for CX3CR1 , 2010, The Journal of Immunology.

[22]  M. Endres,et al.  Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. , 2010, Osteoarthritis and cartilage.

[23]  N. Glaichenhaus,et al.  CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung , 2010, Nature Medicine.

[24]  N. Osada,et al.  The evolution of mammalian chemokine genes. , 2010, Cytokine & growth factor reviews.

[25]  K. Rajarathnam,et al.  Probing the Role of CXC Motif in Chemokine CXCL8 for High Affinity Binding and Activation of CXCR1 and CXCR2 Receptors* , 2010, The Journal of Biological Chemistry.

[26]  K. Kłosowska,et al.  Fractalkine-Induced Endothelial Cell Migration Requires MAP Kinase Signaling , 2010, Pathobiology (Basel).

[27]  P. Allavena,et al.  The chemokine system in cancer biology and therapy. , 2010, Cytokine & growth factor reviews.

[28]  K. Kłosowska,et al.  Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen‐activated protein kinases and Akt , 2009, Clinical and experimental immunology.

[29]  S. Davies,et al.  Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. , 2008, Osteoarthritis and cartilage.

[30]  R. Takahashi,et al.  Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways , 2008, Journal of inflammation research.

[31]  H. Broxmeyer.  Chemokines in hematopoiesis , 2008, Current opinion in hematology.

[32]  M. Juan,et al.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity , 2007, Clinical and experimental immunology.

[33]  H. Makino,et al.  Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients. , 2007, Acta medica Okayama.

[34]  F. Mach,et al.  The specific role of chemokines in atherosclerosis , 2007, Thrombosis and Haemostasis.

[35]  M. Parmentier,et al.  Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies , 2006, Arthritis research & therapy.

[36]  Masao Tanaka,et al.  Fractalkine in rheumatoid arthritis and allied conditions , 2006, Modern rheumatology.

[37]  B. Bresnihan,et al.  Synovial tissue inflammation in early and late osteoarthritis , 2005, Annals of the rheumatic diseases.

[38]  O. Wagner,et al.  Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome , 2005, Thrombosis and Haemostasis.

[39]  T. Imaizumi,et al.  Regulation of CX3CL1/fractalkine expression in endothelial cells. , 2004, Journal of atherosclerosis and thrombosis.

[40]  G. Müller,et al.  Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis. , 2003, The Journal of rheumatology.

[41]  F. Luscinskas,et al.  Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes , 2003, The Journal of experimental medicine.

[42]  N. Miyasaka,et al.  Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[43]  C. Martínez-A,et al.  Analysis of G-protein-coupled receptor dimerization following chemokine signaling. , 2002, Methods.

[44]  E. Butcher,et al.  Chemokines in rapid leukocyte adhesion triggering and migration. , 2002, Seminars in immunology.

[45]  A. Koch,et al.  Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. , 2001, The American journal of pathology.

[46]  D. C. Woodruff,et al.  Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. , 2001, Arthritis and rheumatism.

[47]  B. Cambien,et al.  Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. , 2001, Blood.

[48]  C. Carter,et al.  Fractalkine modulates TNF‐α secretion and neurotoxicity induced by microglial activation , 2000 .

[49]  E. Bettelli,et al.  Arch.Immunol.Ther.Exp. , 2000 .

[50]  J. Bénavidès,et al.  Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. , 2000, Glia.

[51]  C. Sassetti,et al.  Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. , 2000, European journal of immunology.

[52]  T M Handel,et al.  Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. , 1999, Biochemistry.

[53]  H. Nomiyama,et al.  Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q131 , 1998, Cytogenetic and Genome Research.

[54]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[55]  J. Gutiérrez-Ramos,et al.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation , 1997, Nature.

[56]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[57]  D. Taub,et al.  Review of the chemokine meeting the Third International Symposium of Chemotactic Cytokines. , 1993, Cytokine.

[58]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[59]  J. Kellgren,et al.  Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.